换一批
换一批Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes.
第一作者：
J A,Russell
第一单位：
Department of Medicine, Foothills Hospital and Tom Baker Cancer Centre, Calgary, Alberta, Canada. jamesrus@cancerboard.ab.ca
作者：
主题词
青少年(Adolescent);成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);白消安(Busulfan);血液肿瘤(Hematologic Neoplasms);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);注射, 静脉内(Injections, Intravenous);中年人(Middle Aged);骨髓摘除激动剂(Myeloablative Agonists);存活率分析(Survival Analysis);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);阿糖腺苷(Vidarabine)
DOI
10.1053/bbmt.2002.v8.pm12374451
PMID
12374451
发布时间
2022-03-31
- 浏览212
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
